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ABSTRACT Cryptococcus neoformans is a fungal pathogen that kills almost 200,000
people each year and is distinguished by abundant and unique surface glycan struc-
tures that are rich in xylose. A mutant strain of C. neoformans that cannot transport
xylose precursors into the secretory compartment is severely attenuated in virulence
in mice yet surprisingly is not cleared. We found that this strain failed to induce the
nonprotective T helper cell type 2 (Th2) responses characteristic of wild-type infec-
tion, instead promoting sustained interleukin 12p40 (IL-12p40) induction and in-
creased IL-17A (IL-17) production. It also stimulated dendritic cells to release high
levels of proinflammatory cytokines, a behavior we linked to xylose expression. We
further discovered that inducible bronchus-associated lymphoid tissue (iBALT) forms
in response to infection with either wild-type cryptococci or the mutant strain with
reduced surface xylose; although iBALT formation is slowed in the latter case, the
tissue is better organized. Finally, our temporal studies suggest that lymphoid struc-
tures in the lung restrict the spread of mutant fungi for at least 18 weeks after infec-
tion, which is in contrast to ineffective control of the pathogen after infection with
wild-type cells. These studies demonstrate the role of xylose in modulation of host
response to a fungal pathogen and show that cryptococcal infection triggers iBALT
formation.
KEYWORDS Cryptococcus neoformans, encapsulated pathogens, fungal pathogenesis,
iBALT, inducible bronchus-associated lymphoid tissue, pathogenic fungus, pulmonary
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Cryptococcus neoformans is a ubiquitous environmental fungus that causes pneu-monia and meningitis. This opportunistic pathogen infects over one million indi-
viduals each year, with overall mortality exceeding 20% (1–3). Patient immune status is
the main determinant of infection outcome, highlighting the importance of efficient
host immune responses in the control of cryptococcosis.
C. neoformans infection begins when the organism is inhaled, which is followed by
its proliferation in the lungs. This pulmonary infection may then disseminate to the
brain, where it causes a frequently lethal meningoencephalitis. In the lungs, C. neofor-
mans first interacts with host macrophages and dendritic cells (DC). These engulf
the fungus and migrate to draining lymph nodes, where they present antigen to T cells
to initiate the adaptive immune response. The protective immune response to this
infection is primarily mediated by T cells as follows: T helper cell type 1 (Th1) responses
are protective against C. neoformans (4), and T helper type 17 (Th17) responses likely
participate in pathogen clearance at mucosal surfaces (5–7). In contrast, T helper cell
type 2 (Th2) responses are considered detrimental for protective immunity, leading to
fungal growth and facilitating dissemination to the central nervous system (CNS) (8, 9).
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The induction of these nonprotective responses is not well understood, but cryptococ-
cal glycans may contribute to this process (10).
Glycan structures participate in antigen recognition, immune activation, and im-
mune regulation in many organisms (11). In C. neoformans, the major virulence factor,
a polysaccharide capsule, modulates the immune response via multiple mechanisms,
including dampening immune cell activation and impeding phagocytosis (12, 13). The
capsule is primarily composed of two large polysaccharides: glucuronoxylomannan
(GXM) and glucuronoxylomannogalactan (GXMGal) (14, 15). One major component of
both polymers is xylose (Xyl), which comprises almost one-fourth of the polysaccharide
capsule mass (16). Xylose also occurs in cryptococcal glycolipids (17) and as both Xyl
and Xyl-phosphate modifications of protein-linked glycans (18–20). We demonstrate
here that Xyl plays a critical role in the immune recognition of, and response to, C.
neoformans.
The incorporation of Xyl into cryptococcal glycan structures occurs in the lumen of
the secretory pathway via enzymatic reactions that use the substrate molecule UDP-Xyl.
This xylose donor is imported into the synthetic compartment by two transporters, Uxt1
and Uxt2 (21). A mutant strain that lacks both transporters (uxt1Δ uxt2Δ) exhibits
defects in xylosylation, including incomplete synthesis of capsule polysaccharides and
considerable attenuation of virulence in mouse models of infection. Surprisingly,
despite its compromised virulence, which contrasts with the rapid lethality of wild-type
(WT) infection, the mutant strain persists for months in the lungs of infected mice (21).
In pursuing the mechanism of uxt1Δ uxt2Δ strain persistence, we found that
infection with the mutant failed to induce the Th2 responses provoked by WT fungi,
although it did promote production of interleukin 12p40 (IL-12p40) and IL-17, likely via
enhanced stimulation of DCs. The corresponding inflammatory response was enriched
in T and B cells, which were required for the prolonged survival of the infected animals.
Inflammation in the lung, although it increased slowly compared to that in response to
WT infection, appeared to effectively contain the mutant yeast cells for an extended
period after infection. Finally, we observed the formation of inducible bronchus-
associated lymphoid tissue (iBALT) in the lungs of both WT- and uxt1Δ uxt2Δ mutant-
infected mice. iBALT resembles secondary lymphoid organs (lymph nodes) in cellular
composition and organization with two distinctive zones, a central B cell follicle and
surrounding T cell zone (22). The T cell zone contains CD4 and CD8 T cells as well as DCs
(23); the B cell zone contains mainly follicular B cells, and its organization is maintained
by the continuous production of CXCL13 (24). DC activation and cytokine production
are also required for iBALT formation and maintenance (23, 25). In the lungs of mice
infected with the uxt1Δ uxt2Δ mutant, iBALT formation was significantly delayed.
However, once formed, it was better organized than the iBALT produced when mice
were infected with fully xylosylated WT C. neoformans. Together, these results suggest
that luminal Xyl modifications of cryptococcal glycoconjugates alter immune recogni-
tion and activation of immune cells, events that are required for efficient control of C.
neoformans infection.
RESULTS
UDP-Xyl transport is required for cryptococcal virulence and dissemination. We
previously observed that a C. neoformans strain lacking UDP-Xyl transporters (uxt1Δ
uxt2Δ) was highly attenuated in virulence compared to the WT parental strain KN99,
yet remained in the lungs of asymptomatic mice for at least 100 days after infection
(21). While defects in the mutant strain, such as altered capsule and a slightly decreased
growth rate, might explain its reduced virulence, this persistence was surprising. To
investigate the development of this chronic infection, we first examined the kinetics of
fungal burden in mice after intranasal inoculation with WT and mutant strains. In A/JCr
mice infected intranasally with WT fungi, which typically succumb to infection roughly
18 days postinfection (dpi), we observed a rapid and significant increase in pulmonary
fungal burden (Fig. 1A) along with significant dissemination to the spleen (Fig. 1B) and
brain (Fig. 1C). In contrast, the pulmonary burden in uxt1Δ uxt2Δ mutant-infected mice
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increased slowly from initial inoculum levels to a modest peak at 63 dpi (Fig. 1A). CFU
in the lung then gradually declined, although, even after 6 months, only 30% of mice
showed complete clearance (189 dpi) (Fig. 1A). Although uxt1Δ uxt2Δ mutant infection
was not restricted to the lungs, only a fraction of the mice had measurable mutant cells
in the spleen (Fig. 1B) and brain (Fig. 1C) at 63 dpi. Furthermore, this limited dissemi-
nation was only observed at the times of highest lung burden (63 and 126 dpi) with no
fungi detected at distal sites by 189 dpi (Fig. 1B and C).
Cryptococcal xylosylation influences production of pulmonary cytokines and
cellular immune response. We next sought to identify the mechanism(s) responsible
for the unexpected persistence of the uxt1Δ uxt2Δ strain after intranasal infection. As
summarized above, protection against C. neoformans is generally associated with
production of type 1 cytokines like interleukin 2 (IL-2), IL-12, interferon gamma (IFN-),
and tumor necrosis factor alpha (TNF-). In contrast, a Th2 response to cryptococcal
infection (characterized by the production of IL-4, IL-5, and IL-13) compromises control
of pulmonary fungal burden (26) and facilitates dissemination to the central nervous
system (4, 26).
FIG 1 Fungal burden and pulmonary cytokine production in WT- and uxt1Δ uxt2Δ mutant-infected mice. All panels show the combined results
of two independent experiments (5 mice per group per experiment). (A to C) Tissue homogenates of infected A/JCr mice were plated for CFU
at the indicated dpi (open symbols, WT; red symbols, uxt1Δ uxt2Δ strain; dashed line, initial inoculum). Values from individual mice are plotted
along with the mean  standard error of the mean (SEM). (D to I) Cytokine levels in lung homogenates at the indicated dpi (dashed line, naive;
gray bars, WT; red bars, uxt1Δ uxt2Δ strain). *, P  0.05; **, P  0.01; ***, P  0.005 for Student’s t test comparing WT to mutant infection.
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We hypothesized that the protracted host clearance of the uxt1Δ uxt2Δ mutant
reflected an altered host immune response to cells that display reduced xylose. To
assess the host response, we first analyzed cytokine levels over time in lung homog-
enates from mice infected with WT or uxt1Δ uxt2Δ strains (Fig. 1). In mice infected with
WT cryptococci, we observed a strong Th2-type response, with significant induction of
IL-4 and IL-5 over the 15 days prior to sacrifice (Fig. 1D and E). Other proinflammatory
cytokines (IL-1, IL-1, IL-6) were modestly increased (see Fig. S1 in the supplemental
material). In contrast, uxt1Δ uxt2Δ mutant cells elicited a more quiescent Th2 cytokine
response at early stages of infection. Furthermore, at the peak of fungal burden in
uxt1Δ uxt2Δ mutant-infected mice (day 63) (Fig. 1A), there was a significant increase in
the Th1 polarizing cytokine IL-12p40 compared to those levels observed in naive lungs
(Fig. 1F); IL-12p40 levels then slowly declined along with fungal burden. Although the
levels of IFN- and TNF- in mutant-infected mice resembled those in the lungs of
naive mice (Fig. 1G and H), IL-17 trended higher at the peak of infection (Fig. 1I). Overall,
while WT infection rapidly induced nonprotective Th2 responses, infection with the
uxt1Δ uxt2Δ strain failed to do so (even at the peak of fungal burden) and instead
promoted the sustained induction of IL-12p40 and increased production of IL-17.
To measure the host adaptive immune response to the uxt1Δ uxt2Δ strain, we used
flow cytometry to count lymphocytes in the lungs of mice infected with WT or uxt1Δ
uxt2Δ mutant cells. By 15 dpi, the B cell fraction of viable leukocytes in mutant-infected
mice significantly exceeded the value for WT-infected mice (Fig. 2A); this fraction
further increased as mutant infection progressed to peak at over 30%. The same pattern
was seen for CD4 and CD8 T cells (Fig. 2B and C), initiating even earlier (at 12 dpi)
and remaining high throughout the time course. The total numbers of cells in all three
populations remained elevated through 126 dpi (Fig. 2A to C, right), although they
subsequently declined.
Survival of uxt1 uxt2 mutant-infected mice is dependent on T cells. Because
our results suggested that T and B cells play a protective role that contributes to the
prolonged survival of uxt1Δ uxt2Δ mutant-infected mice, we next examined whether
ablation of these cell types altered the course of infection. Because the mouse strains
used for these studies were engineered in the C57BL/6 background, we included
infections of this strain as controls. C57BL/6 mice are less resistant to C. neoformans
than the A/JCr mice used above (27), as shown by their eventual susceptibility to uxt1Δ
uxt2Δ mutant infection (Fig. 2D, solid black line). Notably, Rag1/ mice in this
background were significantly more susceptible to the mutant fungi; all succumbed by
55 dpi (Fig. 2D, solid blue line). These animals still survived longer than WT-infected
mice, possibly due to the slightly slower growth of the mutant, which we previously
observed (21).
Since Rag1/ mice lack both T and B cells, we also infected mice deficient in either
T cells (TCR /) or B cells (MT) with uxt1Δ uxt2Δ strain cryptococci. B cell-deficient
mice exhibited a more protracted course of disease than Rag1/ animals, succumbing
over an 85-day period (Fig. 2D, solid green line), while mice lacking only T cells
succumbed to infection with kinetics similar to those of the Rag1/ mice (Fig. 2D, solid
red line). In contrast, all mice inoculated with WT C. neoformans succumbed by 20 dpi
(Fig. 2D, dashed lines). Of this group, Rag1/ and TCR/ mice still succumbed
slightly faster than C57BL/6 and MT mice (Fig. 2D). Together, these data show that T
cells are the prominent cell type responsible for increased survival of uxt1Δ uxt2Δ
mutant-infected mice, although B cells may play a lesser role in protection.
Reduced surface xylose of C. neoformans stimulates DC activation. The antigen-
driven activation of DCs is critical to induce protective immunity against C. neoformans
(28), and it is likely that their consequent cytokine and chemokine production are
responsible for T cell recruitment (23). We speculated that an enhanced DC response to
xylose-deficient fungi could explain the rise in T cells during uxt1Δ uxt2Δ strain infection
(Fig. 2), even in the absence of expanded numbers of DCs (Fig. 3A). To test this idea, we
grew bone marrow-derived DCs (BMDCs), stimulated them for 24 h with heat-killed C.
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neoformans, and measured the production of proinflammatory cytokines. In these
studies, we used WT fungi, which display antigens modified with Xyl, or uxt1Δ uxt2Δ
mutant fungi, which are impaired in these modifications. We also tested strains with
individual uxt mutations as follows: the uxt1Δ strain shows an intermediate level of Xyl
utilization while the uxt2Δ strain resembles WT (21). Finally, we assayed uxs1Δ mutant
FIG 2 Accumulation of T and B cells in the lungs of mice infected with uxt1Δ uxt2Δ mutant cells is required to
prevent disease progression. CD19 B cells (A), CD4 T cells (B), and CD8 T cells (C) were enumerated in the lungs
of infected mice by flow cytometry (gray, WT; red, uxt1Δ uxt2Δ mutant). Plotted are the combined mean  SEM
values from two independent experiments (5 mice per group per experiment). *, P  0.05; **, P  0.01; ***,
P  0.005 by Student’s t test. (D) Survival of mice after intranasal inoculation with 5  104 cells of the WT (n  5)
or uxt1Δ uxt2Δ strain (n  10). Results shown are combined from two independent experiments. **, P  0.01; ***,
P  0.005 by the log rank test.
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cells, which lack all Xyl modification because they cannot synthesize UDP-Xyl (29), and
an acapsular control strain (cap59Δ) known to induce a potent DC response (30).
We found that bone marrow-derived DCs (BMDCs) cultured with uxt1Δ uxt2Δ
mutant cells released high levels of IL-1 and IL-6, comparable to the levels observed
following exposure to a completely acapsular control strain, the cap59Δ strain (Fig. 3B
and C). In contrast, individual uxt mutants and the uxs1Δ strain induced IL-1 and IL-6
levels similar to those induced by WT fungi (close to background levels) (Fig. 3B and C).
TNF- and IL-12p40 similarly showed the greatest response upon challenge with the
uxt1Δ uxt2Δ strain, with levels like those induced by the acapsular strain, although a
slight increase was also noted with other xylose-deficient strains (uxt1Δ and uxs1Δ
strains) (Fig. 3D and E). These results indicate that early interaction with DCs and
consequent induction of proinflammatory cytokines are influenced by the surface Xyl
expression of C. neoformans.
The cellular response to cryptococcal infection includes the development of
inducible bronchus-associated lymphoid tissue. Our data suggested that uxt1Δ
uxt2Δ mutant cells stimulate elevated production of proinflammatory cytokines by DCs,
which in turn significantly increases the T and B cells in infected lungs (in both absolute
numbers and as a fraction of total leukocytes). Flow cytometry, however, provides no
information as to the distribution of these cell populations within the lung. To further
probe the cellular immune response, we therefore examined lung histology, focusing
FIG 3 Cytokine production by dendritic cells stimulated with cryptococcal antigens. (A) CD11c DC
populations in the lungs of infected mice were quantified by flow analysis. (B to E) DCs were coincubated
for 24 h with heat-killed cells of the strains indicated or subjected to no treatment (no tx), and levels of
IL-1 (B), IL-6 (C), TNF- (D), and IL-12p40 (E) in the supernatant were quantified by ELISA. Shown are the
mean  SD (n  3) values for one representative experiment from five independent experiments that
yielded similar results. **, P  0.01 by one-way ANOVA with Tukey’s post hoc test.
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on late time points of infection as follows: 15 dpi for mice infected with WT fungi and
126 and 189 dpi for uxt1Δ uxt2Δ strain-infected mice (also including 15 dpi to allow
direct comparison to WT). We used Movat’s stain for these studies (Fig. 4) because the
Alcian blue component stains cryptococcal cell walls and capsules turquoise, allowing
visualization of fungi as well as of host cells (31). In WT-infected mice at 15 dpi, we saw
the typical pattern of overwhelming fungal burden throughout the lung, with little
organized inflammation (32). The tissue architecture was largely destroyed, and there
was a preponderance of enlarged fungi with thick capsules. In contrast, mutant-
infected mice at the same time point showed relatively preserved tissue architecture
with limited regions of organized inflammation. Most cryptococci were restricted to
these areas, and overall fungal burden was noticeably lower as expected for this mutant
(Fig. 1A). By 126 dpi with mutant fungi, the regions of inflammation were larger and
more highly consolidated; fungi were rarely observed in other areas of the lung. The
last time point of mutant infection (189 dpi) looked similar, although inflammation
appeared slightly reduced, consistent with the decrease in B and T cells that we
observed at that time point (Fig. 2). Lymphoid structures were also less dense; fungi
were less restricted to the centers of these regions and occasionally appeared in lung
tissue beyond them.
In both groups of mice (WT- and mutant-infected), we noted distinctive lymphocytic
accumulations proximal to the basal side of the bronchial epithelium (Fig. 4). To probe
these structures, we stained lung sections for T cells (CD3), B cells (B220), and plasma
cells (IgG). In all samples, we observed B cell follicles surrounded by CD3 T cell cuffs
(Fig. 5A), suggestive of inducible bronchus-associated lymphoid tissue (iBALT) (24).
Consistent with identification as iBALT, these structures stained positive for CXCL13
(Fig. 5B).
To examine iBALT development, we performed blinded morphometric analysis of
lung tissue from mice infected with WT and mutant cryptococci. At 15 dpi with WT
fungi, we observed numerous iBALT structures with compact B cell follicles surrounded
by T cells (Fig. 5C to E). In contrast, B cell follicles were considerably fewer and less
organized at the same time point in mice infected with the uxt1Δ uxt2Δ strain (Fig. 5C
to E). The limited formation of iBALT structures was also characterized by increased
perivascular accumulation of T cells (Fig. 5A) and decreased production of CXCL13 (Fig.
5B and F). By 126 dpi with the uxt1Δ uxt2Δ strain, however, although iBALT structures
were still less abundant than those found in WT infection (Fig. 5C), their average B cell
follicle size was significantly larger (Fig. 5D). Additionally, the uxt1Δ uxt2Δ mutant iBALT
FIG 4 Mutant cryptococci are primarily restricted to lymphoid structures. Micrographs show Movat-
stained lung sections from A/JCr mice infected with the WT or uxt1Δ uxt2Δ strain as above. Scale bars,
100 m (top row) and 10 m (bottom row). White arrows highlight fungi (stained turquoise). Images
shown are representative of two independent studies (4 to 5 mice per group per experiment).
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was more organized, with reduced T cell cuffing (Fig. 5E), increased CXCL13 (Fig. 5F),
and more IgG plasma cells (Fig. 5A). By 189 dpi, these structures regressed slightly,
consistent with reduced lymphocyte infiltration, cytokine levels, and fungal burden at
this time point. WT cryptococci, thus, induce robust early formation of iBALT, while the
uxt1Δ uxt2Δ mutant induces delayed but ultimately larger and better organized iBALT.
DISCUSSION
We wished to investigate the unexpected observation that a mutant strain of C.
neoformans, despite significant defects in surface glycoconjugates, nevertheless per-
sisted for many months in infected mice. We found that uxt1Δ uxt2Δ mutant cells
showed an initial delay after intranasal infection but then began to accumulate slowly,
eventually rising to a modest peak at which time (63 dpi) we also observed limited
dissemination. The lung burden then began to gradually decline, although by the
endpoint of the study (189 dpi) only three of ten animals had cleared the infection.
The uxt1Δ uxt2Δ mutant induced a generally subdued pulmonary immune response
compared to that induced by WT cryptococci. Notably, levels of IL-12p40, a cytokine
normally required for inducing a protective response against C. neoformans (33), were
elevated at 63 dpi and beyond (Fig. 1F); this may facilitate subsequent resolution of the
uxt1Δ uxt2Δ strain infection. The rise in IL-12p40 could reflect an increase in either IL-23
or IL-12 (34), which stimulate Th17- and Th1-type responses, respectively. Since we
observed a trend toward increased IL-17 at 63 dpi but no difference in IFN- levels,
IL-12p40 was more likely associated with a Th17 response.
In terms of overall lung histology, the early host response of mutant-infected mice
was limited. By 128 dpi, it had become more organized, with all fungi apparently
FIG 5 iBALT complexity in the context of C. neoformans infection. (A and B) Representative immunofluorescent staining of B cells
(B220), T cells (CD3), plasma cells (IgG), and CXCL13 in the lungs of infected A/JCr mice. Scale bar  100 m. (C to E) Morphometric
analysis of iBALT structures in A/JCr mice infected with the WT (gray bars) and uxt1Δ uxt2Δ strain (red bars). (F) Quantification of
immunofluorescent staining of CXCL13. Plots show the combined mean  SEM of two independent studies (4 to 5 mice per group
per experiment); colors as in panels C to E. *, P  0.05; ***, P  0.005 by Student’s t test.
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contained within inflammatory structures, although there was a slight degradation of
fungal control by the last time point imaged (189 dpi). We specifically quantitated the
temporal progression for iBALT and found that B cell follicles at the earliest time point
of mutant infections (15 dpi) were sparse and small compared to 15 dpi wild-type
iBALT, with larger T cell cuffs and smaller areas of CXCL13 staining. By 126 dpi, however,
their follicle size and CXCL3 staining had surpassed WT levels, although these param-
eters regressed somewhat by 189 dpi. The development of iBALT, therefore, paralleled
the ability of the host immune response to physically contain cryptococci within
inflammatory structures in the lung.
DCs reacted more strongly to the uxt1Δ uxt2Δ mutant than to WT in vitro, releasing
greater amounts of proinflammatory cytokines (Fig. 3B to E), even though the global
cytokine response to the mutant was less perturbed (Fig. 1D to I). These cytokines may
directly or indirectly lead to the increased recruitment of T and B cells in uxt1Δ uxt2Δ
mutant infection (Fig. 2A to C) and perhaps accelerate compartmentalization into
compact B cell follicles and discrete T cell areas in iBALT (Fig. 5). Such differences in
cellular composition and organization, coupled with differences in local cytokine
production, may confer distinct properties on iBALT induced by WT and the uxt1Δ
uxt2Δ strain, influencing their ability to protect against C. neoformans.
We expected that the highly immunostimulatory behavior of the uxt1Δ uxt2Δ strain
in vitro reflected the lack of Xyl modifications on its surface glycoconjugates, a conse-
quence of the absence of UDP-Xyl transport into the secretory compartment. We were
surprised, therefore, that mutants unable to synthesize UDP-Xyl (uxs1Δ), which similarly
lack Xyl modifications on secreted glycoconjugates, did not phenocopy this broad and
robust DC response. This suggests that Uxs1 itself is required for the strong response
seen in the absence of xylosylation in the secretory pathway. It may be that this protein
plays additional roles unrelated to glycosylation (35) or that the stimulatory component
is dependent on cytosolic UDP-Xyl rather than UDP-Xyl that has been transported into
the secretory pathway.
Unlike encapsulated strains, C. neoformans mutants lacking capsule induce the
upregulation of multiple genes involved in cytokine responses and enhance antigen
processing and presentation by DCs (36). Interestingly, the cytokine levels induced in
DC by the uxt1Δ uxt2Δ mutant were similar to those induced by the acapsular cap59Δ
mutant (Fig. 4A to C). Xyl may thus be critical for the immune suppressive effects
normally exerted by capsule material. The mechanisms behind the robust DC activation
seen in these two mutants, including the cellular receptors and fungal components
responsible, remain to be determined. It is possible that the uxt1Δ uxt2Δ mutant lacks
immune suppressive mechanisms that are present in WT C. neoformans infection and,
therefore, induces robust cytokine responses and consequent recruitment of T and B
cells that stimulate iBALT formation and limit early infection.
In this study, we report for the first time that C. neoformans infection triggers iBALT
formation. To our knowledge, the only other fungus reported to induce iBALT is
Pneumocystis (37). Notably, the iBALT detected in our experimental infections resem-
bles subpleural nodules that have been observed in cryptococcosis patients (38),
although further examination will be necessary to establish the similarities between
histological features of inflammatory cell infiltration in mice and humans. Although
iBALT formation occurred in mice infected with both mutant and WT fungi, it was
inadequate to defend against the overwhelming fungal burden that rapidly develops in
a standard murine model of cryptococcal infection. It may be that lower inocula would
shift the balance in favor of the host. In any event, the kinetics of iBALT formation and
its organization are dependent on virulence factors of the pathogen. Future studies will
be needed to fully delineate the molecular host-pathogen interactions that drive iBALT
formation following C. neoformans infection and the magnitude of the role that iBALT
plays; in this regard, specific chemokine-deficient mice, such as CXCL13-deficient
animals that lack the ability to induce iBALT structures (39), may be useful.
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Fungal strains. C. neoformans strains (see Table S1 in the supplemental material) were grown at 30°C
in yeast extract-peptone-dextrose (YPD) medium (1% [wt/vol] yeast extract, 2% [wt/vol] peptone, 2%
[wt/vol] dextrose) with shaking (230 rpm) or on YPD agar plates (YPD medium with 2% [wt/vol] agar)
supplemented with the following antibiotics as appropriate: 100 g/ml nourseothricin (NAT) (Werner
BioAgents) or Geneticin (G418; Invitrogen).
Mice. C57BL/6J (RRID IMSR_JAX:000664) and A/JCr (RRID IMSR_CRL:563) mice were obtained from
Jackson Laboratory. Rag1/ (RRID IMSR_JAX:002216), TCR/ (RRID IMSR_JAX:002118), and MT mice
(RRID IMSR_JAX:002288) (all on C57BL/6 background) were generously provided by Michael Diamond
and Wayne Yokoyama (Washington University School of Medicine); breeders were originally purchased
from Jackson Laboratory. All mice were 6 to 8 weeks old at the time of infection. A/JCr mice were female;
male and female mice were used for the other strains with gender and age matched to C57BL/6 controls.
Ethics statement. All animal protocols were reviewed and approved by the Animal Studies Com-
mittee of the Washington University School of Medicine and conducted according to National Institutes
of Health guidelines for housing and care of laboratory animals.
C. neoformans infection. Fungal strains were cultured overnight (O/N) and diluted to 106 cells/ml in
sterile phosphate-buffered saline (PBS). Mice were intranasally inoculated with a 50-l aliquot and then
weighed and monitored daily. Infected mice were sacrificed if they lost 20% relative to peak weight or
at specified time points. At the time of sacrifice, mice were perfused intracardially with 10 ml sterile PBS,
and organs were processed as described below for fungal burden, histology, flow cytometric analysis,
and cytokine measurements.
Organ burden and cytokines. Brain and spleen homogenates were harvested and plated for CFU
at the specified time points. Fifty-microliter aliquots of the left lung homogenates (VT  1 ml) were
similarly plated for CFU. The remaining sample was assayed for pulmonary cytokine levels using the
Bio-Plex protein array system (Bio-Rad Laboratories). Briefly, the lung homogenates were mixed with an
equal volume of PBS/0.1% Triton 100/2 protease inhibitor (Pierce EDTA-free protease inhibitor;
Thermo Scientific), vortexed for 3 s, and clarified by centrifugation (2,500  g, 10 min). Supernatant
fractions were then assayed using the Bio-Plex Pro mouse cytokine 23-plex (Bio-Rad Laboratories) for the
presence of IL-1, IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-17A,
granulocyte colony-stimulating factor (G-CSF), granulocyte monocyte colony-stimulating factor (GM-
CSF), interferon  (IFN-), CXCL1/keratinocyte-derived chemokine (KC), CCL2/monocyte chemotactic
protein-1 (MCP-1), CCL3/macrophage inflammatory protein-1 (MIP-1), CCL4/MIP-1, CCL5/regulated
upon activation normal T cell expressed and secreted (RANTES), and tumor necrosis factor- (TNF-).
Tissue staining and histologic analysis. Mice were perfused intracardially with sterile PBS, and the
lungs inflated with 10% formalin. Lung tissue was then fixed O/N in 10% formalin and submitted to the
Washington University Developmental Biology Histology Core for paraffin embedding and sectioning.
Immunofluorescence staining for B cells (antigen-presenting cell [APC]-conjugated rat anti-mouse
CD45R/B220, clone RA3-6B2; BD Biosciences; RRID AB_627078), T cells (CD3-, clone M-20; Santa Cruz
Biotechnology; RRID AB_631129), IgG plasma cells (fluorescein isothiocyanate [FITC] donkey anti-mouse
IgG; Jackson ImmunoResearch Laboratories; RRID AB_2340796), and CXCL13-producing cells (goat
-mouse CXCL13, AF470; R&D Systems; RRID AB_355378) was performed as in reference 37. Images were
taken with a Zeiss Axioplan 2 microscope and recorded with a Hamamatsu camera. Blinded morpho-
metric analysis of lung structures was performed with the outline tool of Zeiss AxioVision software.
Additional sections were stained with Movat’s pentachrome stain by the Washington University Pulmo-
nary Morphology Core.
Flow cytometric analysis. The right lung of individual mice was enzymatically digested (in 5 ml RPMI
with 1 mg/ml collagenase type IV) at 37°C with shaking (230 rpm) for 30 min and then sequentially
passed through sterile 70- and 40-m pore nylon strainers (BD Biosciences, San Jose, CA). Red blood cells
in the samples were lysed by treatment for 3 min on ice with 5 ml ammonium-chloride-potassium lysing
buffer (8.024 g/liter NH4Cl, 1.001 g/liter KHCO3, 2.722 mg/liter EDTA · Na2 2H2O), followed by the addition
of 2 volumes of PBS. The remaining cells were pelleted (1,000  g, 5 min, 4°C), washed twice with PBS,
diluted to 106 cells/ml in PBS, and stained with LIVE/DEAD fixable blue dead cell stain (1:1,000; Thermo
Scientific). Following incubation in the dark for 30 min at 4°C, cells were washed with PBS and
fluorescence-activated cell sorter (FACS) buffer (2% fetal bovine serum [FBS] in PBS) before resuspension
in FACS buffer. Samples were then blocked with CD16/CD32 (1:500; Fc Block; BD Biosciences; RRID
AB_394656) for 5 min and incubated for 30 min with optimal concentrations of fluorochrome-conjugated
antibodies (see Table S2 in the supplemental material) diluted in brilliant stain buffer (BD Biosciences).
After three washes with FACS buffer, the cells were fixed in 2% formaldehyde/FACS buffer. For data
acquisition, 50,000 events were collected on a BD LSRFortessa X-20 flow cytometer (BD Biosciences),
and the data were analyzed with FlowJo version 10 (see Fig. S1 in the supplemental material; TreeStar).
The absolute number of cells in each leukocyte subset was determined by multiplying the absolute
number of CD45 cells by the percentage of cells stained by fluorochrome-labeled antibodies for each
cell population analyzed.
Isolation of bone marrow-derived cells. Bone marrow was flushed from the femurs and tibiae of
C57BL/6 mice using RPMI. Cells were collected (1,000  g, 5 min, 4°C), resuspended in RPMI, and counted
using a hemocytometer. To prepare bone marrow-derived dendritic cells (BMDCs), 2  106 bone marrow
cells were plated in 10 ml R10 medium (10% FBS, 0.4% penicillin-streptomycin, 2 mM L-glutamate, 50 M
2--mercaptoethanol in RPMI) supplemented with 1 ng/ml GM-CSF and incubated at 37°C and 5% CO2.
Medium was changed 3 and 6 days after plating, and cells were harvested on day 8. BMDCs were
enriched by depletion of bone marrow-derived macrophages using biotinylated -F4/80 antibody
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(eBioscience; RRID AB_466657) and anti-biotin-conjugated magnetic beads (Miltenyi Biotec). The BMDCs
in the flowthrough were positively selected using -CD11c magnetic beads according to the manufac-
turer’s protocol (Miltenyi Biotec).
Dendritic cell assays. To assay the ability of fungal strains to activate BMDCs, C. neoformans strains
of interest were grown O/N, washed in PBS, and incubated at 65°C for 15 min to heat kill (HK) the fungi.
BMDCs and HK fungi (106 cells of each) were then coincubated for 24 h, sedimented, and the supernatant
fractions transferred to 1.5-ml centrifuge tubes containing 10 l of 100 protease inhibitor (Thermo
Scientific). IL-1, IL-6, and TNF- levels in supernatants were determined by enzyme-linked immunosor-
bent assay (ELISA) according to the manufacturer’s protocol (R&D systems).
Statistical analysis. Each experiment was performed a minimum of two times. Statistical analyses
were conducted using GraphPad Prism version 6.0f (GraphPad Software). All studies comparing two
groups were analyzed with a Student’s t test. Those with three or more groups were compared using an
ordinary one-way analysis of variance (ANOVA) with Tukey’s post hoc test. A P value of 0.05 was
considered statistically significant.
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